PSOMAGEN, INC.PSOMAGEN, INC.PSOMAGEN, INC.

PSOMAGEN, INC.

No trades
See on Supercharts
Market capitalization
‪84.73 B‬KRW
−320KRW
‪−4.29 B‬KRW
‪32.31 B‬KRW
‪8.41 M‬
Beta (1Y)
0.48

About PSOMAGEN, INC.


CEO
Soo Hong
Headquarters
Rockville
Founded
2004
ISIN
KR8840150005
FIGI
BBG00TP73DT0
Psomagen, Inc. engages in the provision of genomic, transcriptomic, and proteomic analysis to research programs and operations, serving academic, pharma, biotech, government, and industry. It develops technologies such as short and long-read next-generation sequencing (NGS), Sanger (CE) sequencing, microarray, single-cell omics, metagenomics and microbiome, spatial biology, bioinformatics, and biomarker discovery. The company was founded on December 2, 2004 and is headquartered in Rockville, MD.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.